Michel Detheux

Insider Reports History

Location
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michel Detheux:

Stock Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $10.21 Aug 29, 2025 By MG3A
iTeos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $10.21 Aug 29, 2025 Direct
Vor Biopharma Inc. Director Stock Option (right to buy) 60K Jul 16, 2025 Direct
iTeos Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Aug 29, 2025 By MG3A
iTeos Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 Aug 29, 2025 Direct

Insider Reports Filed by Michel Detheux

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Aug 29, 2025 9 $0 4 Aug 29, 2025 Chief Executive Officer, Director
VOR Vor Biopharma Inc. Jul 16, 2025 1 $0 4 Jul 18, 2025 Director
VOR Vor Biopharma Inc. Jul 16, 2025 0 $0 3 Jul 18, 2025 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2025 16 -$117K 4 Jun 11, 2025 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Jun 4, 2025 18 -$918K 4 Jun 6, 2025 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Mar 7, 2025 2 $0 4 Mar 11, 2025 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Aug 8, 2024 2 $0 4 Aug 9, 2024 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Dec 5, 2023 1 $0 4 Dec 7, 2023 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Mar 9, 2023 3 $0 4 Mar 10, 2023 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Dec 31, 2022 2 $0 5 Mar 10, 2023 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Apr 18, 2022 4 -$318K 4 Apr 19, 2022 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Mar 21, 2022 4 -$630K 4 Mar 22, 2022 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Mar 11, 2022 2 $0 4 Mar 14, 2022 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Feb 23, 2022 2 -$498K 4 Feb 24, 2022 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Jan 25, 2022 2 -$517K 4 Jan 26, 2022 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Dec 2, 2021 23 -$1.85M 4 Dec 22, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Nov 22, 2021 3 -$321K 4 Nov 24, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Nov 1, 2021 3 -$587K 4 Nov 3, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Oct 21, 2021 1 -$5.49K 4 Oct 25, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Oct 15, 2021 2 -$51.4K 4 Oct 19, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Sep 23, 2021 2 -$180K 4 Sep 27, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Sep 1, 2021 3 -$581K 4 Sep 3, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Aug 27, 2021 3 -$412K 4 Aug 31, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Aug 23, 2021 3 -$241K 4 Aug 25, 2021 Chief Executive Officer
ITOS iTeos Therapeutics, Inc. Jun 14, 2021 2 -$827K 4 Jun 16, 2021 Chief Executive Officer, Director